化瘀通络中药对糖尿病肾脏病大鼠肾组织notch和hh信号通路表达的干预作用

《化瘀通络中药对糖尿病肾脏病大鼠肾组织notch和hh信号通路表达的干预作用》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、授予单位代码10089学号或申请号20151087中国图书分类号R2-031HebeiMedicalUniversity博士学位论文学术学位化瘀通络中药对糖尿病肾脏病大鼠肾组织Notch和Hh信号通路表达的干预作用研究生：刘利飞导师：陈志强教授专业：中西医结合基础二级学院：河北省中医院2018年4月目录中文摘要···········································································································1英文摘要····

2、·······································································································5英文缩写··········································································································11研究论文化瘀通络中药对糖尿病肾脏病大鼠肾组织Notch和Hh信号通路表达的干预作用引言·············

3、·····························································································13第一部分化瘀通络中药对糖尿病肾脏病大鼠“瘀血阻络证”的干预作用前言··········································································································15材料与方法·······························

4、·······························································15结果··········································································································19附图·······························································································

5、···········21附表··········································································································24讨论··········································································································27小结·····································

6、·····································································31参考文献··································································································31第二部分化瘀通络中药对糖尿病肾脏病大鼠肾脏损伤的干预作用前言···································································

7、·······································35材料与方法······························································································35结果··········································································································38附图··················

8、························································································40附表····